Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
CHANGE IN RATINGS
(AAP - Get Report) upgraded at Oppenheimer from Underperform to Perform. $75 price target. Sales momentum is improving across the industry.
(BKD - Get Report) upgraded at Morgan Keegan from Market Perform to Outperform. $24 price target. Industry outlook is improving and the FIG sale increases the company's float.
(DF - Get Report)
downgraded at Credit Suisse to Underperform from Neutral. Pricing battle with competitors and higher costs will reduce earnings in 2011. Price target lowered to $7 from $11.
downgraded at Merriman to Neutral. Valuation call, as growth is expected to moderate the next couple of years.
Las Vegas Sands
(LVS - Get Report)
downgraded at UBS from Buy to Neutral. Valuation call, based on a $52 price target.
(SCHW - Get Report)
downgraded at FBR from Outperform to Market Perform. $17 price target. YieldPlus overhang has returned.
downgraded at Sterne Agee to Neutral. $55 price target. Company is facing margin pressure.
(WSM - Get Report)
upgraded at ThinkEquity from Hold to Buy. $40 price target. Sales are recovering faster than expected.